FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AVAIAVAI BIO, INC.

Inspect →

AVALGrupo Aval Acciones Y Valores S.A.

Inspect →

AVATAvalanche Treasury Corp

Inspect →

AVAVAeroVironment Inc

Inspect →

AVBCAvidia Bancorp, Inc.

Inspect →

AVBHAvidbank Holdings, Inc.

Inspect →

AVBPArriVent BioPharma, Inc.

Inspect →

AVCRFAvricore Health Inc.

Inspect →

AVDAMERICAN VANGUARD CORP

Inspect →

AVEXAEVEX Corp.

Inspect →

AVGOBroadcom Inc.

Inspect →

AVIRAtea Pharmaceuticals, Inc.

Inspect →

03 / FINANCIAL CHANGES

Arcutis Biotherapeutics, Inc. ARQT

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-06-30

Filed: 2026-08-05 · Retrieved: 2026-10-16

Compared with the same period of the prior year, ending 2025-06-30.

Revenue129.86

USD million

Change year over year: +48.36 · +59.3%

Net income15.01

USD million

Change year over year: +30.90

Operating cash flow12.64

USD million

Change year over year: +12.32

Total liabilities267.96

USD million

Change year over year: +54.50

Total assets488.54

USD million

Change year over year: +136.10

Liabilities / assets: 54.8% · Change: -5.7 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-25 · Retrieved: 2026-10-16

Compared with the same period of the prior year, ending 2024-12-31.

Revenue372.07

USD million

Change year over year: +205.53 · +123.4%

Net income-16.14

USD million

Change year over year: +123.90

Operating cash flow-5.63

USD million

Change year over year: +106.53

Total liabilities243.49

USD million

Change year over year: +52.15

Total assets432.97

USD million

Change year over year: +84.08

Liabilities / assets: 56.2% · Change: +1.4 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
LGND ↗	2025-12-31	268.09	46.4%	18.4%
BHC ↗	2025-12-31	10,266.00	1.5%	13.6%
REGN ↗	2025-12-31	14,342.90	31.4%	34.7%
LLY ↗	2025-12-31	65,179.00	31.7%	25.8%
BMY ↗	2025-12-31	48,194.00	14.6%	29.4%
PHAT ↗	2025-12-31	175.11	-126.3%	-95.2%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

LH ↗

LABCORP HOLDINGS INC.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

EMN ↗

EASTMAN CHEMICAL CO

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

ATR ↗

APTARGROUP, INC.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

MTX ↗

MINERALS TECHNOLOGIES INC

Filed: 2026-10-30
Period ending: 2026-10-04

Latest standalone quarter

EFOR ↗

Everforth Inc

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

CPSS ↗

CONSUMER PORTFOLIO SERVICES, INC.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

LGND ↗

LIGAND PHARMACEUTICALS INC

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

GILD ↗

GILEAD SCIENCES, INC.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

REGN ↗

REGENERON PHARMACEUTICALS, INC.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

MAN ↗

ManpowerGroup Inc.

Filed: 2026-10-30
Period ending: 2026-09-30

Latest standalone quarter

FLEX ↗

FLEX LTD.

Filed: 2026-10-30
Period ending: 2026-09-25

Latest standalone quarter

ALGM ↗

ALLEGRO MICROSYSTEMS, INC.

Filed: 2026-10-30
Period ending: 2026-09-25

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →